About Clinigen Group PLC
Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: LON
- Symbol: CLIN
- Previous Close: $10.65
- 50 Day Moving Average: $801.21600
- 200 Day Moving Average: $729.34003
- 52-Week Range: £1,145,990 - GBX 492.75
- Trailing P/E Ratio: 72.20014
- P/E Growth: 0.00000
- Market Cap: $980.56B
- Outstanding Shares: 114,599,000
Earnings History for Clinigen Group PLC (LON:CLIN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Clinigen Group PLC (LON:CLIN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Clinigen Group PLC (LON:CLIN)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Clinigen Group PLC (LON:CLIN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/11/2016||John Bacon||Insider||Sell||200,000||GBX 717||£1,434,000|
|10/18/2016||Shaun Edward Chilton||Insider||Sell||97,246||GBX 750||£729,345|
|10/7/2015||Edward Chilton,Shaun||Insider||Sell||412,778||GBX 685||£2,827,529.30|
|6/3/2015||John Hartup||Insider||Sell||23,934||GBX 644||£154,134.96|
Latest Headlines for Clinigen Group PLC (LON:CLIN)
What is Clinigen Group PLC's stock symbol?
Clinigen Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."
How often does Clinigen Group PLC pay dividends? What is the dividend yield for Clinigen Group PLC?
Clinigen Group PLC announced a dividend on Wednesday, September 28th. Shareholders of record on Thursday, November 3rd will be given a dividend of GBX 2.70 per share on Friday, November 25th. This represents a yield of 0.38%. The ex-dividend date is Thursday, November 3rd. This is a boost from Clinigen Group PLC's previous dividend of $1.30. The official announcement can be accessed at this link.
Where is Clinigen Group PLC's stock going? Where will Clinigen Group PLC's stock price be in 2017?
4 equities research analysts have issued 12 month target prices for Clinigen Group PLC's shares. Their predictions range from GBX 895 to GBX 1,000. On average, they expect Clinigen Group PLC's stock price to reach GBX 932 in the next twelve months.
How do I buy Clinigen Group PLC stock?
Shares of Clinigen Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Clinigen Group PLC stock cost?
One share of Clinigen Group PLC stock can currently be purchased for approximately GBX 852.